Holen Sie sich die Stockscreener-App
2.5375
2.87%
-0.0725
Schlusskurs vom Vortag:
$2.61
Offen:
$2.59
24-Stunden-Volumen:
468.33K
Relative Volume:
1.04
Marktkapitalisierung:
$196.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
2.2844
EPS:
1.1108
Netto-Cashflow:
-
1W Leistung:
+13.17%
1M Leistung:
+20.14%
6M Leistung:
-82.02%
1J Leistung:
-82.02%
1-Tages-Spanne:
$2.51
$2.66
1-Wochen-Bereich:
$2.0223
$2.66
52-Wochen-Spanne:
$1.885
$2.695
Accendra Health Inc Stock (ACH) Company Profile
Firmenname
Accendra Health Inc
Sektor
Branche
Telefon
(804) 277-4304
Adresse
10900 NUCKOLS ROAD, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
2.54 | 201.87M | 0 | 0 | 0 | 0.00 |
|
MCK
Mckesson Corporation
|
949.95 | 116.05B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
365.38 | 70.24B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
225.78 | 52.81B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
80.43 | 9.37B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.3969 | 1.16B | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2024-07-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-10-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Fortgesetzt | Citigroup | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-30 | Fortgesetzt | JP Morgan | Underweight |
| 2022-03-23 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-17 | Hochstufung | UBS | Neutral → Buy |
| 2020-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-01-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2019-11-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-10 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Herabstufung | Goldman | Buy → Neutral |
| 2018-09-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Herabstufung | CLSA | Outperform → Sell |
| 2018-04-10 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Hochstufung | Goldman | Sell → Neutral |
| 2017-11-02 | Herabstufung | HSBC Securities | Buy → Hold |
| 2016-03-24 | Hochstufung | Goldman | Sell → Neutral |
| 2015-12-07 | Herabstufung | Goldman | Neutral → Sell |
| 2015-08-31 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Eingeleitet | HSBC Securities | Underweight |
| 2009-08-05 | Hochstufung | Citigroup | Sell → Buy |
| 2008-12-01 | Herabstufung | HSBC Securities | Neutral → Underweight |
Alle ansehen
Accendra Health Inc Aktie (ACH) Neueste Nachrichten
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com India
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com Australia
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
MSN Money - MSN
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
Total debt per share of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Gree Says Won’t Hike Air-Con Prices, Swap Copper for Aluminum Despite Metal’s Surging Cost - Yicai Global
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Total revenue of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
China Metals & Mining Industry Report 2025, Profiles of Jiangxi Copper, China Shenhua Energy Co, Zijin Mining Group, Aluminum Corp of China - Yahoo Finance
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
"Post-70s" Lu Dongliang became Vice Governor of Shanxi Province before becoming Chairman of Aluminum Corporation of China - Shanghai Metals Market
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Chalco’s Stock Tests Investor Nerves As Aluminum Cycle Turns: Is The Worst Finally Priced In? - AD HOC NEWS
Alcoa Corp Is Popping Off: Is AA Stock a Sleepy Boomer Metal Play or a Sneaky Viral Win? - AD HOC NEWS
Accendra Health, Inc.: Dividend historical data and projections - MarketScreener
Accendra Health, Inc.: Target Price Consensus and Analysts Recommendations | 6OM | US6907321029 - MarketScreener
Finanzdaten der Accendra Health Inc-Aktie (ACH)
Es liegen keine Finanzdaten für Accendra Health Inc (ACH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.67%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):